Mechanistic study on the intestinal absorption and disposition of baicalein

European Journal of Pharmaceutical Sciences

Volumn 31, Issue 3-4, 2007, Pages 221-231

  Zhang, Li ^a   Lin, Ge ^a   Kovács, Bernadette ^b   Jani, Márton ^b   Krajcsi, Peter ^b,c   Zuo, Zhong ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b SOLVO BIOTECHNOLOGY   (Hungary)

^c Rational Drug Design Laboratories   (Hungary)

Author keywords

Baicalein; Caco 2; Glucuronidation; MRPs; Sulfation

Indexed keywords

ABC TRANSPORTER; ADENOSINE TRIPHOSPHATASE; BAICALEIN; BAICALEIN 7 GLUCURONIDE; CALCEIN; CARRIER PROTEIN; DRUG METABOLITE; ESTRADIOL DERIVATIVE; GLUCURONIDE; LEUKOTRIENE C4; MULTIDRUG RESISTANCE PROTEIN 1; MULTIDRUG RESISTANCE PROTEIN 2; MULTIDRUG RESISTANCE PROTEIN 3; PROBENECID; PROTEIN MXR; UNCLASSIFIED DRUG; VERLUKAST;

ARTICLE; CELL STRAIN CACO 2; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISPOSITION; DRUG GLUCURONIDATION; DRUG PROTEIN BINDING; DRUG SULFATION; DRUG TRANSPORT; HUMAN; HUMAN CELL; INTESTINE ABSORPTION; MEMBRANE VESICLE; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL TRANSPORT, ACTIVE; CACO-2 CELLS; EGTAZIC ACID; ENZYME INHIBITORS; ESTRADIOL; FLAVANONES; GLUCURONIDES; HUMANS; INTESTINAL ABSORPTION; KINETICS; LEUKOTRIENE C4; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; PERMEABILITY; PROBENECID; PROPIONATES; QUINOLINES; SPECTROPHOTOMETRY, ULTRAVIOLET; SPODOPTERA; SULFURIC ACID ESTERS; TANDEM MASS SPECTROMETRY; VERAPAMIL;

EID: 34249297623     PISSN: 09280987     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejps.2007.04.001     Document Type: Article

References (36)

1. Akao T., Kawabata K., Yanagisawa E., Ishihara K., Mizuhara Y., Wakui Y., Sakashita Y., and Kobashi K. Baicalin, the predominant flavone glucuronide of scutellariae radix, is absorbed from the rat gastrointestinal tract as the aglycone and restored to its original form. J. Pharm. Pharmacol. 52 (2000) 1563-1568
2. Artursson P., and Karlsson J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175 (1991) 880-885
3. Bakos E., Evers R., Sinko E., Varadi A., Borst P., and Sarkadi B. Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol. Pharmacol. 57 (2000) 760-768
4. Barthe L., Woodley J., and Houin G. Gastrointestinal absorption of drugs: methods and studies. Fundam. Clin. Pharmacol. 13 (1999) 154-168
5. Bodo A., Bakos E., Szeri F., Varadi A., and Sarkadi B. Differential modulation of the human liver conjugate transporters MRP2 and MRP3 by bile acids and organic anions. J. Biol. Chem. 278 (2003) 23529-23537
6. Borst P., Evers R., Kool M., and Wijnholds J. A family of drug transporters: the multidrug resistance-associated proteins. J. Natl. Cancer Inst. 92 (2000) 1295-1302
7. Boulenc X., Marti E., Joyeux H., Roques C., Berger Y., and Fabre G. Importance of the paracellular pathway for the transport of a new bisphosphonate using the human Caco-2 monolayers model. Biochem. Pharmacol. 46 (1993) 1591-1600
8. Galijatovic A., Walle U.K., and Walle T. Induction of UDP-glucuronosyltransferase by the flavonoids chrysin and quercetin in Caco-2 cells. Pharm. Res. 17 (2000) 21-26
9. Gutmann H., Hruz P., Zimmermann C., Beglinger C., and Drewe J. Distribution of breast cancer resistance protein (BCRP/ABCG2) mRNA expression along the human GI tract. Biochem. Pharmacol. 70 (2005) 695-699
10. Hirohashi T., Suzuki H., and Sugiyama Y. Characterization of the transport properties of cloned rat multidrug resistance-associate protein 3 (MRP3). J. Biol. Chem. 274 (1999) 15181-15185
11. Hirohashi T., Suzuki H., Chu X.Y., Tamai I., Tsuji A., and Sugiyama Y. Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2). J. Pharmacol. Exp. Ther. 292 (2000) 265-270
12. Hong T., Jin G.B., Cho S., and Cyong J.C. Evaluation of the anti-inflammatory effect of baicalein on dextran sulfate sodium-induced colitis in mice. Planta Med. 68 (2002) 268-271
13. Ilett K.F., Tee L.B.G., Reeves P.T., and Minchin R.F. Metabolism of drugs and other xenobiotics in the gut lumen and wall. Pharmacol. Ther. 46 (1990) 67-93
14. Jeong E.J., Lin H., and Hu M. Disposition mechanisms of raloxifene in the human intestinal Caco-2 model. J. Pharmacol. Exp. Ther. 310 (2004) 376-385
15. Kimata M., Shichijo M., Miura T., Serizawa I., Inagaki N., and Nagai H. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clin. Exp. Allergy 30 (2000) 501-508
16. Lai M.Y., Hsiu S.L., Tsai S.Y., Hou Y.C., and Chao P.D. Comparison of metabolic pharmacokineties of baicalin and baicalein in rats. J. Pharm. Pharmacol. 55 (2003) 205-209
17. Leier I., Jedlitschky G., Buchholz U., Cole S.P., Deeley R.G., and Keppler D. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J. Biol. Chem. 269 (1994) 27807-27810
18. Lespine A., Dupuy J., Orlowski S., Nagy T., Glavinas H., Krajcsi P., and Alvinerie M. Interaction of ivermectin with multidrug resistance proteins (MRP1, 2 and 3). Chem. Biol. Interact 159 (2006) 169-179
19. Liu Y., and Hu M. Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug Metab. Dispos. 30 (2002) 370-377
20. Madon J., Eckhardt U., Gerloff T., Stieger B., and Meier P.J. Functional expression of the rat liver canalicular isoform of the multidrug resistance-associated protein. FEBS Lett. 406 (1997) 75-78
21. Meunier V., Bourrie M., Berger Y., and Fabre G. The human intestinal epithelial cell line Caco-2: pharmacological and pharmacokinetic applications. Cell Biol. Toxicol. 11 (1995) 187-194
22. Muto R., Motozuka T., Nakano M., Tatsumi Y., Sakamoto F., and Kosaka N. The chemical structure of new substance as the metabolite of baicalin and time profiles for the plasma concentration after oral administration of Sho-Saiko-To in human. Yakugaku Zasshi 118 (1998) 79-87
23. Ono K., and Nakane H. Mechanisms of inhibition of various cellular DNA and RNA polymerases by several flavonoids. J. Biol. Chem. 108 (1990) 609-613
24. Pal, A., Mehn, D., Molnar, E.D., Gedey, S., Meszaros, P., Nagy, T., Glavinas, H., Janaky, T., Richter, O.V., Bathori, G., Szente, L., Krajcsi, P., in press. Cholesterol potentiates ABCG2 activity in a heterologous expression system-improved in vitro model to study function of human ABCG2. J. Pharmacol. Exp. Ther. http://jpet.aspetjournals.org/cgi/reprint/jpet.106.119289v1
25. Paulusma C.C., Bosma P.J., Zaman J.R.G., Bakker C.T.M., Otter M., Scheffer G.L., Scheper R.J., Borst P., Oude, and Elferink R.P.J. Congenital jaundice in rats with a mutation in a multidrug resistance-associated protein gene. Science 271 (1996) 1126-1128
26. Prime-Chapman H.M., Fearn R.A., Cooper A.E., Moore V., and Hirst B.H. Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells. J. Pharmacol. Exp. Ther. 311 (2004) 476-484
27. Saitoh H., and Aungst B.J. Possible involvement of multiple Pgp-mediated efflux systems in the transport of verapamil and other organic cations across rat intestine. Pharm. Res. 12 (1995) 1304-1310
28. Sarkadi B., Price E.M., Boucher R.C., Germann U.A., and Scarborough G.A. Expression of the human multidrug resistance cDNA in insect cells generates a high activity drug-stimulated membrane ATPase. J. Biol. Chem. 267 (1992) 4854-4858
29. Shao Z.H., Vanden, Hoek T.L., Qin Y., Becker L.B., Schumacker P.T., Li C.Q., Dey L., Barth E., Halpern H., Rosen G.M., and Yuan C.S. Baicalein attenuates oxidant stress in cardiomyocytes. Am. J. Physiol. 282 (2002) H999-H1006
30. Sun D., Lennernas H., Welage S.L., Barnett J.L., Landowski C.P., Foster D., Fleisher D., Lee K.D., and Amidon G.L. Comparison of human duodenum and Caco-2 gene expression profiles for 12,000 gene sequences tags and correlation with permeability of 26 drugs. Pharm. Res. 19 (2002) 1400-1416
31. Suzuki H., and Sugiyama Y. Role of metabolic enzymes and efflux transporters in the absorption of drugs from the small intestine. Eur. J. Pharm. Sci. 12 (2000) 3-12
32. Vaidyanathan J.B., and Walle T. Transport and metabolism of the tea flavonoid (-)-epicatechin by the human intestinal cell line Caco-2. Pharm. Res. 18 (2001) 1420-1425
33. Yang D., Hu H., Huang S., Chaumont J.P., and Millet J. Study on the inhibitory activity, in vitro, of baicalein and baicalin against skin fungi and bacteria. Zhong Yao Cai 23 (2000) 272-274
34. Zhang L., Zheng Y., Chow M., and Zuo Z. Investigation of intestinal absorption and disposition of green tea catechins by Caco-2 monolayer model. Int. J. Pharm. 287 (2004) 1-12
35. Zhang L., Lin G., Chang Q., and Zuo Z. Role of intestinal first-pass metabolism during the absorption process of baicalein. Pharm. Res. 22 (2005) 1050-1058
36. Zhang L., Lin G., and Zuo Z. Involvement of UDP-glucuronosyltransferases in the extensive liver and intestinal first-pass metabolism of flavonoid baicalein. Pharm. Res. 24 (2007) 81-89